Silence Therapeutics PLC Cash Flow Quality Index
Silence Therapeutics PLC cash flow quality index. Silence Therapeutics PLC (SLN) has a Cash Flow Quality Index of -0.87x as of December 2024. Operating cash flow of $-19.87 Million is below net income of $22.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SLN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Silence Therapeutics PLC Cash Flow Quality Index by Year (None–None)
Silence Therapeutics PLC cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Silence Therapeutics PLC. For the full cash flow conversion analysis, see how efficiently does Silence Therapeutics PLC generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|